Preferred Label : Bevacizumab/Ixabepilone Regimen;
NCIt synonyms : Bevacizumab/Ixabepilone; Ixabepilone/Bevacizumab; Ixabepilone-Bevacizumab; Bevacizumab-Ixabepilone; Ixempra/Avastin; Avastin/Ixempra;
NCIt related terms : Ixabepilone and Bevacizumab-onbe; Ixabepilone and Bevacizumab-maly; Ixabepilone and Bevacizumab-adcd; Ixabepilone and Bevacizumab-awwb; Ixabepilone and Bevacizumab-aybi; Ixabepilone and Bevacizumab-bvzr; Ixabepilone and Bevacizumab-equi; Ixabepilone and Bevacizumab;
NCIt definition : A regimen consisting of bevacizumab and ixabepilone that can be used for the treatment
of breast, ovarian, fallopian tube, and primary peritoneal cancers.;
NCI Metathesaurus CUI : CL1913049;
Codes from synonyms : 127508; 127360; 127582; 127286; 14102; 127212; 127434; 127656;
Origin ID : C192896;
UMLS CUI : C5785495;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
